Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

SMALL-CAP WINNERS & LOSERS: Hansa rises; Ondo InsurTech loss widens

3rd Dec 2025 10:25

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday.

----------

SMALL-CAP - WINNERS

----------

Hansa Investment Co Ltd, up 2.6% at 278.00 pence, 12-month range 294.00p-190.00p. The closed-ended investment company says court approves planned all-share merger with investment firm Ocean Wilsons. It notes that Ocean Wilsons will now take steps to submit the final court order to the court for sealing. The firm adds that Ocean Wilsons can only complete the combination once the sealed court order has been issued.

----------

Solvonis Therapeutics PLC, up 3.8% at 0.25p, 12-month range 0.40p-0.11p. The London-based biopharmaceutical company focused on addiction and mental health disorders says its novel compound SVN-015 has been accepted into the US National Institute on Drug Abuse's addiction treatment discovery programme. The firm says the compound targets methamphetamine and cocaine use disorders. Under the programme, NIDA, which is part of the US National Institutes of Health, will fund and conduct early preclinical evaluation of the compound. "Being accepted into NIDA's ATDP for SVN-015 is a major step forward for Solvonis... For methamphetamine and cocaine addiction - where no approved drug treatments exist - this represents an important advance," says Chief Scientific Officer David Nutt.

----------

SMALL-CAP - LOSERS

----------

Ondo InsurTech PLC, down 17% at 24.95p, 12-month range 44.00p-20.67p. The claim prevention technology company says its pretax loss widens to GBP3.9 million in the six months to the end of September from GBP2.4 million a year ago. Revenue jumps 26% to GBP2.1 million from GBP1.7 million while administrative expenses climb 28% to GBP3.2 million from GBP2.5 million. The company says it expects revenue in the current year to be between GBP4.5 million and GBP5.0 million and that the earnings before interest, tax, depreciation and amortisation loss will be between GBP5.0 million and GBP5.5 million. Ondo ends the period with cash of GBP600,000. The firm says it intends to secure GBP2.2 million in a fundraise to new and existing institutional investors and other investors. It says the fundraising will be at a price of 25p per share in a placing to raise not less than GBP1.4 million, a direct subscription to raise GBP760,000 and a retail offering to existing shareholders. It says the net proceeds will be used to accelerate the firm's commercial progress in the US through the expansion of US plumber coverage and infrastructure.

----------

By Michael Hennessey, Alliance News reporter

Comments and questions to [email protected]

Copyright 2025 Alliance News Ltd. All Rights Reserved.


Related Shares:

Solvonis TherapHansa Inv.Ondo Insurtech
FTSE 100 Latest
Value9,687.06
Change-14.74